Nobel Biocare: Slight improvement but situation remains more than challenging

SELL, Fair Value CHF8.9 (-10%)

News published on February Tuesday 19, 2013
Share on

Revenue for 2012 was EUR580.5m (consensus : EUR578.5m) driven once again by the Americas (39% of sales, +1.8% CER). EMEA remained under pressure (41% of sales, -3.6% CER) while Asia/Pacific (21% of sales, -8.6% CER) suffered from a media campaign in Japan where the market was down 15% and represents 60% of regional revenue.

Full report available to subscribers
Please contact

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities